Form 4: Clorox Director Boosts Stake with DSU Acquisitions

Clorox Director Christopher J. Williams increased his beneficial ownership of the company's stock through the acquisition of Deferred Stock Units via dividend reinvestment, annual awards, and director fee conversions.

Summary

• Christopher J. Williams, a Director of The Clorox Company, acquired a total of 2,137.6273 Deferred Stock Units (DSUs) across three separate transactions.
• On November 6, 2025, 227.0333 DSUs were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
• On December 31, 2025, 1,637.8577 DSUs were acquired as an annual award pursuant to the 2005 Stock Incentive Plan.
• Also on December 31, 2025, an additional 272.7363 DSUs were received in lieu of quarterly director's fees.
• The DSUs will be settled 100% in Clorox common stock upon Mr. Williams' retirement or other termination of service as a Director.
• Following these transactions, Mr. Williams' direct beneficial ownership of Deferred Stock Units increased to 21,596.5756.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director increasing their stake, even through compensation, generally signals confidence in the company's long-term prospects and aligns their interests with shareholders.

Positives

• Increased beneficial ownership by a director signals confidence in the company's future performance and aligns management interests with shareholders.
• The acquisition of Deferred Stock Units through various compensation mechanisms demonstrates a structured approach to director remuneration and long-term incentive alignment.

Future Outlook

The Deferred Stock Units acquired by the director will be settled 100% in Clorox common stock upon his retirement or other termination of service as a Director, indicating a future conversion of these units into shares.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, which is a standard practice across publicly traded companies to align the interests of directors with those of shareholders. It does not provide broader industry trends or competitive insights.

Corporate Governance

Related Party Transactions

• Acquisition of Deferred Stock Units by a director as part of their compensation package, which is a standard related-party transaction for public companies.

Stakeholder Impact

• Shareholders: Increased director ownership can be viewed positively as it aligns the director's financial interests with those of the shareholders, potentially leading to more shareholder-friendly decisions.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Settlement of Deferred Stock Units into Clorox common stock upon the reporting person's retirement or termination of service as a Director.

Key Dates

Recommendation

This Form 4 details routine insider transactions related to director compensation, which are generally expected and do not typically indicate a significant shift in the company's fundamental outlook. While increased insider ownership is a minor positive signal of confidence, it is not substantial enough on its own to warrant a 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive alignment without suggesting a strong market move.

Keywords

Clorox, CLX, Director, Insider Transaction, Deferred Stock Units, DSU, Compensation, Equity, Stock Incentive Plan, Corporate Governance